These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1752118)

  • 21. Lorazepam: effects on sleep and withdrawal phenomena.
    Kales A; Bixler EO; Soldatos CR; Jacoby JA; Kales JD
    Pharmacology; 1986; 32(3):121-30. PubMed ID: 3960963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pravastatin on human sleep.
    Kamei Y; Shirakawa S; Ishizuka Y; Usui A; Uchiyama M; Watanabe T; Fukuzawa H; Kariya T
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):643-6. PubMed ID: 8301881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers.
    Lee TM; Lin MS; Tsai CH; Chang NC
    Kidney Int; 2005 Aug; 68(2):779-87. PubMed ID: 16014056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme-A reductase, pravastatin and simvastatin, on colony formation by hematopoietic progenitor cells].
    Kunitama M; Komatsu N; Miura Y
    Rinsho Ketsueki; 1996 Nov; 37(11):1314-7. PubMed ID: 8960668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.
    Mitler MM; Seidel WF; van den Hoed J; Greenblatt DJ; Dement WC
    J Clin Psychopharmacol; 1984 Feb; 4(1):2-13. PubMed ID: 6141188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A.
    Horsmans Y; Desager JP; van den Berge V; Abrassart M; Harvengt C
    Pharmacol Res; 1993; 28(3):243-8. PubMed ID: 8108314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of therapeutic interchange from pravastatin to lovastatin in a Veterans Affairs Medical Center.
    Patel RJ; Gray DR; Pierce R; Jafari M
    Am J Manag Care; 1999 Apr; 5(4):465-74. PubMed ID: 10387386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia.
    Fosso CK; Miller MJ; Solomon WR; Baker JR
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):1053-5. PubMed ID: 7751504
    [No Abstract]   [Full Text] [Related]  

  • 31. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
    J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of diltiazem with lovastatin and pravastatin.
    Azie NE; Brater DC; Becker PA; Jones DR; Hall SD
    Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin.
    Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Baner K; Benet LZ; Sewing KF; Christians U
    J Pharmacol Exp Ther; 1999 Oct; 291(1):131-9. PubMed ID: 10490896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
    Steinhagen-Thiessen E
    Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alprazolam: effects on sleep and withdrawal phenomena.
    Kales A; Bixler EO; Vela-Bueno A; Soldatos CR; Manfredi RL
    J Clin Pharmacol; 1987 Jul; 27(7):508-15. PubMed ID: 3655003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
    Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
    J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors.
    Krasovec M; Elsner P; Burg G
    Dermatology; 1993; 186(4):248-52. PubMed ID: 8513188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different effects of the hypolipidemic drugs pravastatin and lovastatin on the cholesterol biosynthesis of the human ocular lens in organ culture and on the cholesterol content of the rat lens in vivo.
    de Vries AC; Cohen LH
    Biochim Biophys Acta; 1993 Mar; 1167(1):63-9. PubMed ID: 8461334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.
    Pierno S; De Luca A; Tricarico D; Roselli A; Natuzzi F; Ferrannini E; Laico M; Camerino DC
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1490-6. PubMed ID: 8531120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.